Extreme Turbulence Injures 11 on Delta Flight from Milan to Georgia
Aviation experts, Slack
"Despite improvements in technology, turbulence encounters continue to be an airline safety issue," said pilot and aviation expert, Ladd Sanger of Slack
Turbulence can be caused by a variety of weather phenomena and varies in severity. According to Sanger, "severe turbulence can cause large and abrupt changes in altitude, large aircraft movements and changes in airspeed and the airplane may be difficult to control. In some instances of extreme or severe turbulence, structural damage to the aircraft can occur and there is a serious risk of injury to aircraft occupants who are not properly restrained."
Sanger points out that the Delta turbulence event will invoke the application of the Montreal Convention of 1999 ("Montreal Convention"), which is an international treaty that applies to airline passenger injuries that occur on an international flight. The Montreal Convention imposes strict liability upon an airline for an injury occurring during a flight, without regard to whether the event was the result of airline negligence. Sanger adds, "The Montreal Convention was adopted to address this very type of situation. The injured passengers can recover damages for their injuries without having to prove the airline knew or should have known about the risk of a turbulence encounter."
Since 1993, Slack Davis Sanger has been representing aviation passengers nationally and internationally, with a combined experience of more than 150 years. To learn more about claims arising from turbulence or to speak with aviation partners
View original content:https://www.prnewswire.com/news-releases/extreme-turbulence-injures-11-on-delta-flight-from-milan-to-georgia-301915337.html
SOURCE Slack
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agentic AI Foundation Launches MCPA Certification to Validate MCP Expertise
- Best Franchise Business Brokers in the US List Released: Top Firms for Selling a Franchise Business Compared by Experts
- Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share